ZA9711533B - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
ZA9711533B
ZA9711533B ZA9711533A ZA9711533A ZA9711533B ZA 9711533 B ZA9711533 B ZA 9711533B ZA 9711533 A ZA9711533 A ZA 9711533A ZA 9711533 A ZA9711533 A ZA 9711533A ZA 9711533 B ZA9711533 B ZA 9711533B
Authority
ZA
South Africa
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Application number
ZA9711533A
Inventor
Stephen Martin Courtney
David Iain Carter Scopes
Robert Forbes Burns
Original Assignee
Oxford Glycosciences Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences Uk Ltd filed Critical Oxford Glycosciences Uk Ltd
Publication of ZA9711533B publication Critical patent/ZA9711533B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA9711533A 1996-12-20 1997-12-22 Therapeutic compounds ZA9711533B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9626450.2A GB9626450D0 (en) 1996-12-20 1996-12-20 Therapeutic compounds

Publications (1)

Publication Number Publication Date
ZA9711533B true ZA9711533B (en) 1999-06-22

Family

ID=10804731

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9711533A ZA9711533B (en) 1996-12-20 1997-12-22 Therapeutic compounds

Country Status (5)

Country Link
EP (1) EP0946581A1 (en)
AU (1) AU5330198A (en)
GB (1) GB9626450D0 (en)
WO (1) WO1998028318A1 (en)
ZA (1) ZA9711533B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE204878T1 (en) * 1995-06-23 2001-09-15 Oxford Glycosciences Uk Ltd THERAPEUTIC COMPOUNDS
AUPQ872300A0 (en) * 2000-07-11 2000-08-03 Praxis Pharmaceuticals Pty Ltd Compounds and methods
WO2018209255A1 (en) 2017-05-12 2018-11-15 Galectin Sciences, Llc Compounds for the prevention and treatment of diseases and the use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149818C (en) * 1976-10-28 1987-04-06 Sankyo Co ANALOGY PROCEDURE FOR PREPARING 5-FLUORURACIL DERIVATIVES
JPS5872599A (en) * 1981-10-27 1983-04-30 Kanto Ishi Pharma Co Ltd Conjugated glycoside derivative
EP0119650A3 (en) * 1983-03-21 1987-09-30 THE PROCTER & GAMBLE COMPANY Galactosyl-insulin conjugates useful in treating diabetics
JP3667359B2 (en) * 1993-12-29 2005-07-06 扶桑薬品工業株式会社 Preparation and pharmaceutical composition of 5-fluorouridine derivatives

Also Published As

Publication number Publication date
WO1998028318A1 (en) 1998-07-02
GB9626450D0 (en) 1997-02-05
EP0946581A1 (en) 1999-10-06
AU5330198A (en) 1998-07-17

Similar Documents

Publication Publication Date Title
ZA983176B (en) Therapeutic compounds
GB9421709D0 (en) Therapeutic compounds
AP9600895A0 (en) Therapeutic compounds
GB9601724D0 (en) Therapeutic agents
AP2002002661A0 (en) Combination therapy for oesteoporosis
GB9600235D0 (en) Therapeutic agents
GB9603755D0 (en) Therapeutic agents
ZA973209B (en) Therapeutic compounds.
GB9600143D0 (en) Therapeutic compounds
GB9613969D0 (en) Therapeutic agents
GB9615449D0 (en) Therapeutic agents
GB9605065D0 (en) Therapeutic agents
GB9609374D0 (en) Therapeutic agents
GB9620777D0 (en) Therapeutic use
GB9716345D0 (en) Therapeutic compounds
GB9716347D0 (en) Therapeutic compounds
GB9716344D0 (en) Therapeutic compounds
ZA9711533B (en) Therapeutic compounds
GB9610979D0 (en) Therapeutic agents
GB9604036D0 (en) Therapeutic agents
GB9603136D0 (en) Therapeutic agents
ZA977005B (en) Therapeutic uses
GB9608372D0 (en) Therapeutic compounds
GB9608547D0 (en) Therapeutic compounds
GB9613017D0 (en) Therapeutic compounds